Cayman Chemical HArgGlyAspCysOHtrIfluo 50mg
A platelet aggregation inhibitor inhibits ADP- collagen- or epinephrine-induced platelet aggregation in isolated human platelets (IC50s 730 92 and 3.4 UM respectively) inhibits arachidonic acid-induced platelet aggregation and TXA2 production in isolated rat platelets (IC50s 3.3 and 32.8 UM respectively) reduces LPS-induced contractions in isolated endothelium-denuded rat aortic strips in a concentration-dependent manner decreases thrombus weight in a rat model of arterio-venous shunt thrombosis at 50 mg/kg increases survival in a mouse model of septicemia induced by LPS at 10 and 20 mg/kg